As a leader in Xcenda’s Global Health Economics & Outcomes Research group, I conduct a broad range of global HEOR engagements including economic modeling, comparative effectiveness research, and strategic HEOR assessment.
My experience includes preparing economic dossiers for reimbursement and regulatory submissions in the US and abroad, risk assessment using longitudinal databases and model training for a wide range of users. I have expertise across several disease areas including cardiovascular disease, atherothrombosis, anticoagulation, neurology, infectious disease, and orphan diseases.
I serve as a peer reviewer
to many journals and congresses and have authored numerous publications
appearing in PharmacoEconomics, Value in Health, American Journal of Medicine, Journal
of Cardiac Failure, Canadian Journal
of Diabetes, Journal of Medical
Ergonomics, and others.
I have also held the role of
Senior Decision Scientist at the Institute for Clinical and Economic Review
(ICER) where I was responsible for developing and executing the economic models
and assessments for comparative effectiveness appraisals. I have also
specialized in disease course modeling, risk assessment, and global health
economic evaluations.
I earned a Bachelor of Science in Psychology with a focus on research methods and statistics from Denison University and completed 2 years of graduate studies in Psychology at the University of New Hampshire.